These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24315978)

  • 1. Role of PPAR, LXR, and PXR in epidermal homeostasis and inflammation.
    Schmuth M; Moosbrugger-Martinz V; Blunder S; Dubrac S
    Biochim Biophys Acta; 2014 Mar; 1841(3):463-73. PubMed ID: 24315978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology.
    Schmuth M; Jiang YJ; Dubrac S; Elias PM; Feingold KR
    J Lipid Res; 2008 Mar; 49(3):499-509. PubMed ID: 18182682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptors and nonalcoholic fatty liver disease.
    Cave MC; Clair HB; Hardesty JE; Falkner KC; Feng W; Clark BJ; Sidey J; Shi H; Aqel BA; McClain CJ; Prough RA
    Biochim Biophys Acta; 2016 Sep; 1859(9):1083-1099. PubMed ID: 26962021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing.
    Man MQ; Choi EH; Schmuth M; Crumrine D; Uchida Y; Elias PM; Holleran WM; Feingold KR
    J Invest Dermatol; 2006 Feb; 126(2):386-92. PubMed ID: 16374473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
    Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
    Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity.
    Kidani Y; Bensinger SJ
    Immunol Rev; 2012 Sep; 249(1):72-83. PubMed ID: 22889216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor β and peroxisome proliferator-activated receptor δ regulate cholesterol transport in murine cholangiocytes.
    Xia X; Jung D; Webb P; Zhang A; Zhang B; Li L; Ayers SD; Gabbi C; Ueno Y; Gustafsson JÅ; Alpini G; Moore DD; Lesage GD
    Hepatology; 2012 Dec; 56(6):2288-96. PubMed ID: 22729460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPAR and LXR activators regulate ABCA12 expression in human keratinocytes.
    Jiang YJ; Lu B; Kim P; Paragh G; Schmitz G; Elias PM; Feingold KR
    J Invest Dermatol; 2008 Jan; 128(1):104-9. PubMed ID: 17611579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential.
    Gong H; Xie W
    Expert Opin Ther Targets; 2004 Feb; 8(1):49-54. PubMed ID: 14996618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators.
    Hatano Y; Man MQ; Uchida Y; Crumrine D; Mauro TM; Feingold KR; Elias PM; Holleran WM
    J Allergy Clin Immunol; 2010 Jan; 125(1):160-9.e1-5. PubMed ID: 19818482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.
    Andersen V; Christensen J; Ernst A; Jacobsen BA; Tjønneland A; Krarup HB; Vogel U
    World J Gastroenterol; 2011 Jan; 17(2):197-206. PubMed ID: 21245992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of LXRα induces lipogenesis in HaCaT cells.
    Hong I; Rho HS; Kim DH; Lee MO
    Arch Pharm Res; 2010 Sep; 33(9):1443-9. PubMed ID: 20945144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis.
    Demerjian M; Choi EH; Man MQ; Chang S; Elias PM; Feingold KR
    Exp Dermatol; 2009 Jul; 18(7):643-9. PubMed ID: 19236478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of ABCA12 in epidermal lipid barrier formation and keratinocyte differentiation.
    Akiyama M
    Biochim Biophys Acta; 2014 Mar; 1841(3):435-40. PubMed ID: 23954554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-activated transcription factors control bile acid glucuronidation.
    Barbier O; Trottier J; Kaeding J; Caron P; Verreault M
    Mol Cell Biochem; 2009 Jun; 326(1-2):3-8. PubMed ID: 19130183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes.
    Schmuth M; Haqq CM; Cairns WJ; Holder JC; Dorsam S; Chang S; Lau P; Fowler AJ; Chuang G; Moser AH; Brown BE; Mao-Qiang M; Uchida Y; Schoonjans K; Auwerx J; Chambon P; Willson TM; Elias PM; Feingold KR
    J Invest Dermatol; 2004 Apr; 122(4):971-83. PubMed ID: 15102088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte-derived IL-1β induces PPARG downregulation and PPARD upregulation in human reconstructed epidermis following barrier impairment.
    Blunder S; Krimbacher T; Moosbrugger-Martinz V; Gruber R; Schmuth M; Dubrac S
    Exp Dermatol; 2021 Sep; 30(9):1298-1308. PubMed ID: 33683743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes.
    Jiang YJ; Kim P; Elias PM; Feingold KR
    J Lipid Res; 2005 Dec; 46(12):2657-66. PubMed ID: 16150827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of constitutive androstane receptor and its cross talk with liver X receptors and peroxisome proliferator-activated receptor A in lipid metabolism.
    Xiao L; Wang J; Jiang M; Xie W; Zhai Y
    Vitam Horm; 2013; 91():243-58. PubMed ID: 23374719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation.
    Mencarelli A; Distrutti E; Renga B; D'Amore C; Cipriani S; Palladino G; Donini A; Ricci P; Fiorucci S
    PLoS One; 2011; 6(7):e22978. PubMed ID: 21829567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.